Evidence map›Paper›PMID 31851672›Full record

ArticlePloS one2019

Clinically-defined preoperative serum phosphorus abnormalities and outcomes of coronary artery bypass grafting: Retrospective analysis using inverse probability weighting adjustment.

Jungchan Park, Kwan Young Hong, Jeong Jin Min, Eunjin Kwon, Young Tak Lee, Wook Sung Kim, Hye Seung Kim, Kyunga Kim, Jong-Hwan Lee

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jungchan ParkDepartment of Anesthesiology and Pain Medicine, Samsung Medical Center, Sung Kyunkwan University School of Medicine, Seoul, Korea.
Kwan Young HongDepartment of Anesthesiology and Pain Medicine, Samsung Medical Center, Sung Kyunkwan University School of Medicine, Seoul, Korea.ORCID 0000-0001-6213-1848
Jeong Jin MinDepartment of Anesthesiology and Pain Medicine, Samsung Medical Center, Sung Kyunkwan University School of Medicine, Seoul, Korea.
Eunjin KwonDepartment of Anesthesiology and Pain Medicine, Samsung Medical Center, Sung Kyunkwan University School of Medicine, Seoul, Korea.
Young Tak LeeDepartment of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Wook Sung KimDepartment of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Hye Seung KimStatistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Kyunga KimStatistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Jong-Hwan LeeDepartment of Anesthesiology and Pain Medicine, Samsung Medical Center, Sung Kyunkwan University School of Medicine, Seoul, Korea.ORCID 0000-0001-8249-5550
Samsung Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerum phosphorus is a well-known marker of vascular calcification, but the effects of serum phosphorus abnormalities defined by clinical criteria on the outcomes of coronary artery bypass grafting (CABG) remain unclear. We aimed to evaluate whether preoperative serum phosphorus abnormalities defined based on clinical criteria are associated with outcomes of CABG using a relatively new statistical technique, inverse probability weighting (IPW) adjustment.

methodsFrom January 2001 to December 2014, 4,989 consecutive patients who underwent CABG were stratified into normal (2.5-4.5 mg/dl; n = 4,544), hypophosphatemia (<2.5 mg/dl; n = 238), or hyperphophatemia (>4.5 mg/dl; n = 207) groups depending on preoperative serum phosphorus level.

resultsThe primary outcome was all-cause death during a median follow-up of 48 months. Secondary outcomes were cardiovascular death, graft failure, myocardial infarction, repeat revascularization, and stroke. In multivariate Cox analysis, preoperative hypophosphatemia was significantly associated with all-cause death (hazard ratio [HR] 1.76; 95% confidence interval [CI] 1.13-2.76; P = 0.01). However, this association varied depending on chronic kidney disease and emergent operation (p for interaction = 0.05 and 0.03, respectively). In addition, analysis after IPW adjustment demonstrated that preoperative serum phosphorus abnormalities were not significantly associated with all-cause death (P = 0.08) or any secondary outcomes except graft failure. Graft failure was significantly associated with preoperative hypophosphatemia (HR 2.51; 95% CI 1.37-4.61; P = 0.003).

conclusionOur study showed that preoperative serum phosphorus abnormalities in clinical criteria were not associated with outcomes after CABG except for graft failure. And, the association of hypophosphatemia with graft failure remains to be evaluated.

Indexed as

Coronary Artery BypassAgedBiomarkersCoronary Artery DiseaseHumansHyperphosphatemiaHypophosphatemiaMaleMiddle AgedPhosphorusPreoperative PeriodProportional Hazards ModelsRetrospective StudiesTreatment OutcomeBiomarkersPhosphorus

Identifiers

PMID31851672
PMCPMC6919634
OpenAlexW2995336959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.